ENDOMETRIAL HYPERPLASIA IN AN OOPHORECTOMIZED WOMAN RECEIVING TAMOXIFEN THERAPY - CASE-REPORT

被引:41
作者
CROSS, SS [1 ]
ISMAIL, SM [1 ]
机构
[1] UNIV COLL CARDIFF,DEPT PATHOL,CARDIFF CF4 4XN,S GLAM,WALES
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1990年 / 97卷 / 02期
关键词
D O I
10.1111/j.1471-0528.1990.tb01748.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:190 / 192
页数:3
相关论文
共 8 条
[1]  
BOCCARDO F, 1981, ONCOLOGY, V38, P281, DOI 10.1159/000225571
[2]  
FORNANDER T, 1989, LANCET, V1, P117
[3]   EFFECT OF ANTI-OESTROGEN TAMOXIFEN ON PLASMA-LEVELS OF LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, PROLACTIN, ESTRADIOL AND PROGESTERONE IN NORMAL PREMENOPAUSAL WOMEN [J].
GROOM, GV ;
GRIFFITHS, K .
JOURNAL OF ENDOCRINOLOGY, 1976, 70 (03) :421-428
[4]  
HENDRICKSON M, 1980, MAJOR PROBLEMS PATHO, V12, P285
[5]  
KILLACKEY MA, 1985, CANCER TREAT REP, V69, P237
[6]  
KURMAN RJ, 1987, BLAUSTEINS PATHOLOGY, P34
[7]  
NEUMANNOVA M, 1985, OBSTET GYNECOL, V66, P695
[8]   ENDOCRINE CONSEQUENCES OF CONTINUOUS ANTI-ESTROGEN THERAPY WITH TAMOXIFEN IN PREMENOPAUSAL WOMEN [J].
SHERMAN, BM ;
CHAPLER, FK ;
CRICKARD, K ;
WYCOFF, D .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) :398-404